妊娠期糖尿病、子痫前期及健康妊娠女性孕期与产后心脏结构、功能及能量代谢评估
本研究纳入健康妊娠38例、妊娠期糖尿病30例、子痫前期20例及非妊娠超重与正常体重对照各10例,用心脏磁共振波谱与成像评估心肌能量代谢及左心室结构与功能。孕晚期妊娠期糖尿病和子痫前期组左心室质量高于健康妊娠组,磷酸肌酸/三磷酸腺苷比值及整体纵向缩短低于健康妊娠组;产后12个月各组左心室质量、磷酸肌酸/三磷酸腺苷比值及整体纵向缩短均无显著变化。
要点
- 孕晚期妊娠期糖尿病和子痫前期组左心室质量高于健康妊娠组,磷酸肌酸/三磷酸腺苷比值及整体纵向缩短低于健康妊娠组。
- 产后12个月各组左心室质量、磷酸肌酸/三磷酸腺苷比值及整体纵向缩短均无显著变化。
- 妊娠期糖尿病与子痫前期组之间孕期及产后左心室质量、磷酸肌酸/三磷酸腺苷比值及整体纵向缩短均无显著差异。
核心结论
- 妊娠期糖尿病或子痫前期女性孕期表现出相似的心肌表型,产后12个月左心室质量、能量代谢及整体纵向缩短的亚临床改变持续存在。
- 这些心肌改变与非妊娠超重对照者相似,可能主要受超重/肥胖驱动。
研究设计与样本
- 研究纳入健康妊娠38例、妊娠期糖尿病30例、子痫前期20例、非妊娠超重对照10例及正常体重对照10例。
- 采用心脏磁共振波谱与成像评估心肌能量代谢(磷酸肌酸/三磷酸腺苷比值)、左心室容积、质量、射血分数及整体纵向缩短。
- 妊娠组在产后12个月重复扫描,未产对照仅评估一次。
主要发现
- 孕晚期与健康妊娠组相比,妊娠期糖尿病和子痫前期组体重指数更高、左心室质量更高(健康妊娠组90[85,94]g,妊娠期糖尿病组103[96,112]g,子痫前期组118[111,125]g;P=.001)。
- 孕晚期与健康妊娠组相比,妊娠期糖尿病和子痫前期组磷酸肌酸/三磷酸腺苷比值更低(健康妊娠组2.2[2.1,2.4],妊娠期糖尿病组1.9[1.7,2],子痫前期组1.9[1.8,2.1];P=.0004)。
- 孕晚期与健康妊娠组相比,妊娠期糖尿病和子痫前期组整体纵向缩短更低(健康妊娠组20[18,21]%,妊娠期糖尿病组18[17,19]%,子痫前期组16[14,17]%;P=.01)。
- 产后各组左心室质量、磷酸肌酸/三磷酸腺苷比值及整体纵向缩短均无显著变化。
- 妊娠期糖尿病与子痫前期组之间孕期及产后左心室质量、磷酸肌酸/三磷酸腺苷比值及整体纵向缩短均无显著差异;非妊娠超重对照左心室质量53[43,63]g、磷酸肌酸/三磷酸腺苷比值2.0[1.8,2.2]、整体纵向缩短-19[17,21]%,与妊娠期糖尿病或子痫前期组孕期及产后相比均无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gestational diabetes mellitus (GDM) and preeclampsia are common complications of pregnancy, for which overweight/obesity is a common risk factor. Both conditions are associated with a two-to-four-fold increase in future incident heart failure, which may be linked to early maladaptive myocardial changes. OBJECTIVE: To determine maternal myocardial structural, functional, and energetic responses to pregnancies complicated by GDM or preeclampsia compared to healthy pregnancies (HP) at third-trimester of pregnancy and 12-months postpartum. STUDY DESIGN: Thirty-eight women with HP, 30 GDM, 20 preeclampsia, 10 nonpregnant controls with overweight (Overweight-NC), and 10 with normal-weight were recruited. Cardiovascular magnetic resonance spectroscopy and imaging were used to define myocardial energetics (phosphocreatine: ATP ratio [PCr/ATP]), left ventricular (LV) volumes, mass, and ejection fraction and global longitudinal shortening (GLS). Pregnancy groups underwent repeat scans 12-months postpartum, nulliparous-controls were assessed once. RESULTS: During third-trimester, compared to HP, women with either GDM or preeclampsia displayed higher BMI, higher LV-mass (HP: 90 [85, 94] g, GDM: 103 [96, 112], Preeclampsia: 118 [111, 125] g; P=.001) and lower PCr/ATP (HP: 2.2 [2.1, 2.4], GDM: 1.9 [1.7, 2], Preeclampsia: 1.9 [1.8, 2.1]; P=.0004) and GLS (HP: 20 [18, 21]%, GDM: 18 [17, 19]%, Preeclampsia: 16 [14, 17]%; P=.01). Post-pregnancy, no group saw significant changes in LV-mass, PCr/ATP, or GLS. There were no significant differences in LV-mass, PCr/ATP or GLS between the GDM and preeclampsia groups during or post-pregnancy. Moreover, the Overweight-NC showed no significant differences in LV-mass (53 [43, 63])g, PCr/ATP (2.0 [1.8, 2.2]), or GLS (-19 [17, 21]%) compared to GDM or preeclampsia groups during or post-pregnancy. CONCLUSION: Women with GDM or preeclampsia exhibit similar myocardial phenotypes during pregnancy with persistent subclinical alterations in LV mass, energetics, and GLS 12-months postpartum. These myocardial alterations are similar to those detected in Overweight-NC, potentially suggesting the myocardial changes may predominantly be driven by overweight/obesity.
引用
- Thirunavukarasu S, Ansari F, Kotha S, et al. Cardiac structural, functional, and energetic assessments during and after pregnancy in women with gestational diabetes mellitus, preeclampsia, and healthy pregnancy. Am J Obstet Gynecol. 2024. PMID: 39581289. doi:10.1016/j.ajog.2024.11.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。